Malaria prophylaxis in the traveler

被引:1
作者
Capdevila, J. A. [1 ]
Icart, R. [2 ]
机构
[1] Hosp Mataro, Med Interna Serv, Barcelona, Spain
[2] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain
来源
REVISTA CLINICA ESPANOLA | 2010年 / 210卷 / 02期
关键词
Malaria; Previention; Antimalaria drugs;
D O I
10.1016/j.rce.2009.06.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Malaria is a preventable and curable disease. The risk zones are those tropical and subtropical regions of the countries with endemic malaria. These countries are visited by 125 million international tourists yearly and it is estimated that up to 30,000 fait sick with malaria. Prevention is done by: preventing transmission (using mosquito repellent, mosquito nets, etc.) and by preventing the disease by chemoprophylaxis. The tatter aims to reduce the risk of suffering severe malaria, basically that produced by P. falciparum. It consists in the administration of antimalaria drugs before, during and after the trip. The choice of antimalaria drug will depend on the individual factors (allergies, contra-indications, etc.) and mainly on the resistance of P falciparum to these drugs. In areas with sensitivity to chloroquine, this should be the drug of choice and in those with resistances, three drugs have been recommended by both the CDC and WHO: Atovaquone/proguanil, Doxycycline and Mefloquine (C) 2009 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:77 / 83
页数:7
相关论文
共 50 条
  • [11] Failure of atovaquone-proguanil malaria chemoprophylaxis in a traveler to Ghana
    Boggild, Andrea K.
    Lau, Rachel
    Reynaud, Denis
    Kain, Kevin C.
    Gerson, Marvin
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2015, 13 (01) : 89 - 93
  • [12] Travel advice for the immunocompromised traveler: prophylaxis, vaccination, and other preventive measures
    Patel, Rupa R.
    Liang, Stephen Y.
    Koolwal, Pooja
    Kuhlmann, Frederick Matthew
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 217 - 228
  • [13] Prophylaxis and therapy of malaria -: state of the art
    Lutterbach, C
    Lösch, R
    MEDIZINISCHE WELT, 2000, 51 (05): : 9 - 16
  • [14] Recent advances in the prophylaxis and treatment of malaria
    Labbé A.-C.
    Loutfy M.R.
    Kain K.C.
    Current Infectious Disease Reports, 2001, 3 (1) : 68 - 76
  • [15] Mefloquine as a prophylaxis for malaria needs to be revisited
    Ahmad, Sundus Shafat
    Rahi, Manju
    Ranjan, Vikash
    Sharma, Amit
    INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE, 2021, 17 : 23 - 26
  • [16] TRENDS AND CONTROVERSIES IN THE PROPHYLAXIS AND TREATMENT OF MALARIA
    BIA, FJ
    INFECTIOUS AGENTS AND DISEASE-REVIEWS ISSUES AND COMMENTARY, 1992, 1 (02): : 108 - 113
  • [17] Malaria in the Traveler: How to Manage Before Departure and Evaluate Upon Return
    Hahn, William O.
    Pottinger, Paul S.
    MEDICAL CLINICS OF NORTH AMERICA, 2016, 100 (02) : 289 - +
  • [18] Malaria in immigrant and traveler children: Clinical presentation and risk factors for complications
    Lavoie, Pascal M.
    Carceller, Ana
    Robert, Monique
    Lebel, Marc H.
    Moore, Dorothy L.
    Rashed, Selim
    JOURNAL OF PEDIATRIC INFECTIOUS DISEASES, 2006, 1 (01) : 29 - 37
  • [19] Atovaquone-proguanil for prophylaxis and treatment of malaria
    Marra, F
    Salzman, JR
    Ensom, MHH
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (09) : 1266 - 1275
  • [20] Organization of prophylaxis, diagnosis and treatment for malaria in France
    Bouchaud, O
    MEDECINE ET MALADIES INFECTIEUSES, 1999, 29 : 286S - 294S